MATURATION OF CAFFEINE ELIMINATION IN INFANCY

被引:120
作者
ARANDA, JV
COLLINGE, JM
ZINMAN, R
WATTERS, G
机构
[1] MCGILL UNIV,DEPT PHARMACOL & THERAPEUT,ROCHE DEV PHARMACOL UNIT,MONTREAL H3C 3G1,QUEBEC,CANADA
[2] MCGILL UNIV,MONTREAL CHILDRENS HOSP,DEPT PAEDIAT,MONTREAL H3H 1P3,QUEBEC,CANADA
[3] MCGILL UNIV,MONTREAL CHILDRENS HOSP,DEPT NEUROL,MONTREAL H3H 1P3,QUEBEC,CANADA
关键词
D O I
10.1136/adc.54.12.946
中图分类号
R72 [儿科学];
学科分类号
100202 ;
摘要
The developmental changes in caffeine elimination were studied in 7 infants aged between 2/1/2 weeks and 6 months. Adult plasma clearance rate of caffeine was achieved at 3 to 4/1/2 months of age. Plasma half-life and elimination rate reached adult levels after 3 to 4/1/2 months and seemed to exceed adult capacity thereafter. No significant changes in apparent volume of distribution were noted. Our data provide some indication of the age in infancy when the low rates of caffeine elimination in the neonate increase to the adult rate.
引用
收藏
页码:946 / 949
页数:4
相关论文
共 28 条
  • [11] GREENBAUM J, 1977, ANN ALLERGY, V39, P69
  • [12] HORNING M, 1977, P FASEB HEARING CAFF, P28
  • [13] DRUG-METABOLISM IN HUMAN NEONATE
    HORNING, MG
    BUTLER, CM
    NOWLIN, J
    HILL, RM
    [J]. LIFE SCIENCES, 1975, 16 (05) : 651 - 671
  • [14] PLASMA CONCENTRATIONS OF PHENOBARBITAL IN TREATMENT OF SEIZURES IN NEWBORNS
    JALLING, B
    [J]. ACTA PAEDIATRICA SCANDINAVICA, 1975, 64 (03): : 514 - 524
  • [15] PHARMACOKINETIC OBSERVATIONS OF PHENYTOIN DISPOSITION IN NEWBORN AND YOUNG INFANT
    LOUGHNAN, PM
    GREENWALD, A
    PURTON, WW
    ARANDA, JV
    WATTERS, G
    NEIMS, AH
    [J]. ARCHIVES OF DISEASE IN CHILDHOOD, 1977, 52 (04) : 302 - 309
  • [16] PHARMACOKINETIC ANALYSIS OF DISPOSITION OF INTRAVENOUS THEOPHYLLINE IN YOUNG CHILDREN
    LOUGHNAN, PM
    SITAR, DS
    OGILVIE, RI
    EISEN, A
    FOX, Z
    NEIMS, AH
    [J]. JOURNAL OF PEDIATRICS, 1976, 88 (05) : 874 - 879
  • [17] MULTIPLICITY OF CYTOCHROMES P-450 DURING DEVELOPMENT
    MANCHESTER, DK
    NEIMS, AH
    [J]. PEDIATRIC RESEARCH, 1977, 11 (04) : 418 - 418
  • [18] MORSELLI PL, 1975, BASIC THERAPEUTIC AS, P377
  • [19] DEVELOPMENTAL ASPECTS OF HEPATIC CYTOCHROME P450 MONOOXYGENASE SYSTEM
    NEIMS, AH
    WARNER, M
    LOUGHNAN, PM
    ARANDA, JV
    [J]. ANNUAL REVIEW OF PHARMACOLOGY AND TOXICOLOGY, 1976, 16 : 427 - 445
  • [20] CLINICAL PHARMACOKINETICS OF THEOPHYLLINE
    OGILVIE, RI
    [J]. CLINICAL PHARMACOKINETICS, 1978, 3 (04) : 267 - 293